Yukiko Onishi

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes

Dominik Dahl, Yukiko Onishi, Paul Norwood et al. · JAMA · 2022 · 512 citations · Full text

Angiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling

Takehide Ogihara, Tomoichiro Asano, Katsuyuki Ando et al. · Hypertension · 2002 · 272 citations · Full text

Hypertension, Insulin Signaling, Oxidative Stress +19

Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.

Hideyuki Sakoda, Takehide Ogihara, Motonobu Anai et al. · Diabetes · 2000 · 231 citations · Full text

Glucocorticoid, Glucose Uptake, Insulin Signaling +19

Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells

Nobuhiro Shojima, Hideyuki Sakoda, Takehide Ogihara et al. · Diabetes · 2002 · 210 citations · Full text

Molecular Regulation, Adipokines, Mouse Adipose Cells +27